Home > Web Log >

ID: 1638837377

Monday, December 6, 2021

Elsevier's "Pharmacological Research" has published an article on ivermectin this January, Ivermectin, a potential anticancer drug derived from an antiparasitic drug .

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase. On the other hand, ivermectin promotes programmed cancer cell death, including apoptosis, autophagy and pyroptosis. Ivermectin induces apoptosis and autophagy is mutually regulated. Interestingly, ivermectin can also inhibit tumor stem cells and reverse multidrug resistance and exerts the optimal effect when used in combination with other chemotherapy drugs.

1638837377 - 4:36 PM - drugs, health, science